Commentary: Evaluation of Models of Parkinson's Disease

dc.creatorMuñoz, Patricia
dc.creatorParis Pizarro, Irmgard
dc.creatorSegura Aguilar, Juan
dc.date.accessioned2016-09-06T14:25:06Z
dc.date.available2016-09-06T14:25:06Z
dc.date.created2016-09-06T14:25:06Z
dc.date.issued2016-04
dc.identifierFrontiers in Neuroscience Volumen: 10 Número de artículo: 161 (2016)
dc.identifier1662-453X
dc.identifier10.3389/fnins.716.00161
dc.identifierhttps://repositorio.uchile.cl/handle/2250/140313
dc.languageen
dc.publisherFrontiers Media
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceFrontiers in Neuroscience
dc.subjectPreclinical models
dc.subjectParkinson therapy
dc.subjectAminochrome
dc.subjectDopamine
dc.subjectNeurodegeneration
dc.subjectMPTP
dc.subject6-hydroxidopamine
dc.subjectL-dopa
dc.titleCommentary: Evaluation of Models of Parkinson's Disease
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución